Figure 2.
Figure 2. Phenotype and activation patterns of Vδ2TEMh and Vδ2TEMRA lymphocytes. (A) NKR and chemokine receptors of representative TEMh (top panels) and TEMRA (bottom panels) TCR Vδ2+ clones. Cultured Vδ2 T-cell clones are characterized as Vδ2TEMh on the basis of their CD16–CD45RA– perforinlow pheno-type, or as Vδ2TEMRA when they are CD16+CD45RA+ perforinhigh (mean fluorescence intensity [MFI] for intracellular perforin is given). (B) Vδ2TEMh and Vδ2TEMRA PBMCs freshly drawn from a healthy donor with different levels of cell surface TCR Vδ2. (C) PhosphoERK immunoblots of lysates from Vδ2high and Vδ2low cells (5 × 105 cells/point). After sorting using gates shown in panel B, in vitro activation of the collected cells, and production of their lysates, the p-Erk immunoblots reveal a higher response to BrHPP in Vδ2TEMh than in Vδ2TEMRA, which respond better to stimulation with anti-CD16. The data are representative of 2 independent experiments on different donors.

Phenotype and activation patterns of Vδ2TEMhand Vδ2TEMRAlymphocytes. (A) NKR and chemokine receptors of representative TEMh (top panels) and TEMRA (bottom panels) TCR Vδ2+ clones. Cultured Vδ2 T-cell clones are characterized as Vδ2TEMh on the basis of their CD16CD45RA perforinlow pheno-type, or as Vδ2TEMRA when they are CD16+CD45RA+ perforinhigh (mean fluorescence intensity [MFI] for intracellular perforin is given). (B) Vδ2TEMh and Vδ2TEMRA PBMCs freshly drawn from a healthy donor with different levels of cell surface TCR Vδ2. (C) PhosphoERK immunoblots of lysates from Vδ2high and Vδ2low cells (5 × 105 cells/point). After sorting using gates shown in panel B, in vitro activation of the collected cells, and production of their lysates, the p-Erk immunoblots reveal a higher response to BrHPP in Vδ2TEMh than in Vδ2TEMRA, which respond better to stimulation with anti-CD16. The data are representative of 2 independent experiments on different donors.

Close Modal

or Create an Account

Close Modal
Close Modal